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Herein, we report the association of a rare muscle disease, macrophagic myofascitis, 
with Japanese rheumatoid arthritis (RA). Our case was not related to aluminum 
containing vaccinations and the respective etiologies are unknown. The possible link 
needs to be discussed. 
 
Introduction  
Macrophagic myofascitis (MMF) is known to be associated with vaccinations 
containing aluminum as an adjuvant.1) Herein, we describe a case of MMF unrelated to 
vaccination that presented as focal muscle tenderness in a Japanese patient with 
rheumatoid arthritis (RA). Magnetic resonance imaging showed evidence of unilateral 
myofascitis involving the anterior tibialis muscles. Muscle biopsy showed a 
pathological pattern typical of MMF. This observation suggests that the appearance of 
focal myalgia during the course of rheumatic diseases must arouse the suspicion of an 






A 53 year-old Japanese woman was admitted to our hospital due to stiffness and 
myalgia of the lower extremities on January 28, 2008. She had been diagnosed with 
rheumatoid arthritis and had been treated with methotrexate for 2 years. Three months 
prior to admission, she had complained of myalgia of the left lower extremities and gait 
disturbance as a consequence of the pain of these lesions. She had no history of 
immunization containing aluminum during the past 20 years.  
On physical examination, her blood pressure was 120/72 mm Hg, pulse 82/min, 
and body temperature 36.6°C. Focal tenderness in the left lower limbs was noted with 
mild muscle weakness. Laboratory examination, including blood counts, biochemistry, 
thyroid function and angiotensin-converting enzyme (ACE) were normal. Mild 
elevations of CK (278 IU/ml) and aldolase (9.1 IU/ml) were noted. Serological tests for 
anti-neutrophil cytoplasmic autoantibodies (ANCA), cryoglobulin, Epstein-Barr virus, 
Parvovirus, hepatitis B and C virus were all negative. Cytomegalovirus antigen was not 
detected. Both the sedimentation rate (ESR) and the serum C-reactive protein (CRP) 
were slightly elevated (ESR 27mn/hr, CRP 1.11mg/dl). Anti-nuclear antibodies (ANA) 
were positive with low titers (´ 40, speckled pattern) and anti-cyclic citrullinated 
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peptide antibodies were also detected (54.1 IU/ml; normal range <4.5IU/ml). Magnetic 
resonance imaging (MRI) of the left lower limbs showed hyper intense signals in the 
fascia of the left anterior tibialis muscle suggesting fascial inflammation (Figure 1). 
Muscle biopsy obtained from the anterior tibialis muscles revealed the massive 
infiltration of macrophages in the perifascial regions (Figure 2A). There was neither 
granuloma nor vasculitis. The macrophages were CD68-positive (Figure 2B) and some 
macrophages exhibited cytoplasm filled with periodic acid Schiff (PAS)-positive 
material (Figure 2C). The findings typical of cytophagic histiocytic panniculitis were 
not observed. Muscle necrosis in association with lymphocytic infiltration, typical 
finding for myositis was also not observed. The patient was diagnosed as having MMF. 
The elevated levels of CK and aldolase were normalized by a moderate dose of 
corticosteroid (prednisolone 20mg/day), however, her symptoms were not improved. 
Therefore, we added tacrolimus in addition to the corticosteroid treatments. Treatment 







Macrophagic myofascitis is an unusual inflammatory myopathy, which has 
almost exclusively been reported in French adults with diffuse arthromyalgia.1) 
Diagnosis is based on muscle biopsy that usually shows specific histological 
abnormalities characterized by dense infiltration of CD68+ macrophages with basophilic 
periodic acid-schiff (PAS)-positive content. 1)  We report a Japanese patient with MMF 
that was accompanied by RA, independent of vaccination. The clinical symptoms, 
affecting the lower limbs, and pathological findings were quite typical of MMF in the 
presence of remarkable myofascial involvement. Laboratory tests only showed slight 
elevations of muscle enzyme levels.  
The role of vaccines containing aluminum hydroxide in the pathogenesis of 
MMF has been suggested. 2)  However, there is a discrepancy between the wide usage 
of aluminum hydroxide-containing vaccines and the very limited numbers of reported 
cases of MMF. Furthermore, systemic symptoms are observed despite the fact that 
histological abnormalities are present only at the site of vaccination. This case report 
suggests that additional factors, other than vaccination, may influence the occurrence of 
MMF. Many patients with MMF exhibit preexisting autoimmune diseases, including 
thyroiditis, systemic lupus erythematosus, Sjögren’s syndrome and RA. 3)  The 
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association of MMF with autoimmune diseases suggests that autoimmune mechanisms 
might play a critical role in its pathogenesis. Chronic immune stimulation, which results 
from persistence of aluminum hydroxide, has been proposed as a possible cause of 
MMF. 4)  While a chance association between MMF and RA cannot be ruled out, 
RA-related altered immunity, such as inflammatory cytokine regulation, may contribute 
to the occurrence of MMF. The direct connection between MMF and RA remains 
unclear. However, one interpretation of the occurrence of both MMF and RA in our 
patient suggests that immune activation contributed to the macrophage perifascicular 
infiltration and subsequent fascicular inflammation. 
Some efficacies have been reported for a variety of treatments against MMF, 
including antibiotics, glucocorticoids and immunosuppressants. 1, 5, 6)  Tacrolimus is an 
immunosuppressant that is widely used in transplantation and rheumatoid arthritis. 7)  
The primary immunosuppressive effect of tacrolimus is suppression of activated T cells 
via calcineurin inhibition, however, actions against monocytes have also been 
demonstrated. 8)  Interestingly, Ida et al. reported the impressive effect of tacrolimus in 
TNF receptor-associated periodic syndrome (TRAPs), which is characterized by 
monocytic fasciitis due to the uncontrolled macrophage activation. 9)  Further clinical 
studies are required to evaluate the efficacy of newer immunosuppressive agents, 
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including tacrolimus, for the treatment of resistant cases of MMF.  
In summary, the findings of the present case suggest that MMF is rarely 
observed in the Japanese population, independent of vaccination. It is likely that MMF 
remains under-diagnosed and clinicians should consider MMF in focal myalgia with 
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Figure 1 STIR axial magnetic resonance imaging demonstrating a high intensity signal 
in the fascia of the left anterior tibialis muscle. 
 
Figure 2: Findings of lt anterior tibialis muscle biopsy  
A: Massive perifascicular infiltration of large macrophages (Hematoxylin-eosin; 
original magnification ́ 100) 
B: CD68+ immunoreactivity showing a large predominance of macrophages. 
(immunoperoxidase procedure; original magnification×400) 
C: Focal perifascicular accumulation of macrophages filled with PAS-positive materials. 
(periodic acid Schiff; original magnification×400). 
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
Figure 2A 
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Figure 2B 
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Figure 2C 
 
